These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 20692977)
1. The use of in vitro reconstituted human skin in dermotoxicity testing. Roguet R; Régnier M; Cohen C; Dossou KG; Rougier A Toxicol In Vitro; 1994 Aug; 8(4):635-9. PubMed ID: 20692977 [TBL] [Abstract][Full Text] [Related]
2. Characterization and applications of human epidermis reconstructed in vitro on de-epidermized derma. Parnigotto PP; Bernuzzo S; Bruno P; Conconi MT; Montesi F Farmaco; 1998 Feb; 53(2):125-31. PubMed ID: 9604320 [TBL] [Abstract][Full Text] [Related]
3. Improved barrier structure formation in air-exposed human keratinocyte culture systems. Fartasch M; Ponec M J Invest Dermatol; 1994 Mar; 102(3):366-74. PubMed ID: 8120421 [TBL] [Abstract][Full Text] [Related]
4. Episkin, a reconstituted human epidermis for assessing in vitro the irritancy of topically applied compounds. Roguet R; Cohen C; Dossou KG; Rougier A Toxicol In Vitro; 1994 Apr; 8(2):283-91. PubMed ID: 20692918 [TBL] [Abstract][Full Text] [Related]
5. Measurement of cytotoxicity and irritancy potential of sugar-based surfactants on skin-related 3D models. Lu B; Miao Y; Vigneron P; Chagnault V; Grand E; Wadouachi A; Postel D; Pezron I; Egles C; Vayssade M Toxicol In Vitro; 2017 Apr; 40():305-312. PubMed ID: 28163247 [TBL] [Abstract][Full Text] [Related]
6. Barrier function of human skin and human reconstructed epidermis. Regnier M; Caron D; Reichert U; Schaefer H J Pharm Sci; 1993 Apr; 82(4):404-7. PubMed ID: 8468685 [TBL] [Abstract][Full Text] [Related]
7. Characterization of reconstructed skin models. Ponec M; Boelsma E; Gibbs S; Mommaas M Skin Pharmacol Appl Skin Physiol; 2002; 15 Suppl 1():4-17. PubMed ID: 12476005 [TBL] [Abstract][Full Text] [Related]
8. The living skin equivalent: Its manufacture, its organotypic properties and its responses to irritants. Bell E; Parenteau N; Gay R; Nolte C; Kemp P; Bilbo P; Ekstein B; Johnson E Toxicol In Vitro; 1991; 5(5-6):591-6. PubMed ID: 20732083 [TBL] [Abstract][Full Text] [Related]
9. Permeability barrier properties of oral keratinocyte cultures: a model of intact human oral mucosa. Selvaratnam L; Cruchley AT; Navsaria H; Wertz PW; Hagi-Pavli EP; Leigh IM; Squier CA; Williams DM Oral Dis; 2001 Jul; 7(4):252-8. PubMed ID: 11575877 [TBL] [Abstract][Full Text] [Related]
10. Permeability of the reconstructed human epidermis model Episkin in comparison to various human skin preparations. Netzlaff F; Kaca M; Bock U; Haltner-Ukomadu E; Meiers P; Lehr CM; Schaefer UF Eur J Pharm Biopharm; 2007 Apr; 66(1):127-34. PubMed ID: 17029766 [TBL] [Abstract][Full Text] [Related]
11. Development of genotoxicity test procedures with Episkin, a reconstructed human skin model: towards new tools for in vitro risk assessment of dermally applied compounds? Flamand N; Marrot L; Belaidi JP; Bourouf L; Dourille E; Feltes M; Meunier JR Mutat Res; 2006 Jul; 606(1-2):39-51. PubMed ID: 16675293 [TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor and temperature regulate keratinocyte differentiation. Ponec M; Gibbs S; Weerheim A; Kempenaar J; Mulder A; Mommaas AM Arch Dermatol Res; 1997 May; 289(6):317-26. PubMed ID: 9209676 [TBL] [Abstract][Full Text] [Related]
13. The ECVAM international validation study on in vitro tests for acute skin irritation: report on the validity of the EPISKIN and EpiDerm assays and on the Skin Integrity Function Test. Spielmann H; Hoffmann S; Liebsch M; Botham P; Fentem JH; Eskes C; Roguet R; Cotovio J; Cole T; Worth A; Heylings J; Jones P; Robles C; Kandárová H; Gamer A; Remmele M; Curren R; Raabe H; Cockshott A; Gerner I; Zuang V Altern Lab Anim; 2007 Dec; 35(6):559-601. PubMed ID: 18186667 [TBL] [Abstract][Full Text] [Related]
14. The human epidermis models EpiSkin, SkinEthic and EpiDerm: an evaluation of morphology and their suitability for testing phototoxicity, irritancy, corrosivity, and substance transport. Netzlaff F; Lehr CM; Wertz PW; Schaefer UF Eur J Pharm Biopharm; 2005 Jul; 60(2):167-78. PubMed ID: 15913972 [TBL] [Abstract][Full Text] [Related]
15. Assessment of the potential irritancy of oleic acid on human skin: Evaluation in vitro and in vivo. Boelsma E; Tanojo H; Boddé HE; Ponec M Toxicol In Vitro; 1996 Dec; 10(6):729-42. PubMed ID: 20650257 [TBL] [Abstract][Full Text] [Related]
16. In vitro cultured human skin cells as alternatives to animals for skin irritancy screening. Ponec M Int J Cosmet Sci; 1992 Dec; 14(6):245-64. PubMed ID: 19272110 [TBL] [Abstract][Full Text] [Related]
17. Epidermal Penetration of Gold Nanoparticles and Its Underlying Mechanism Based on Human Reconstructed 3D Episkin Model. Hao F; Jin X; Liu QS; Zhou Q; Jiang G ACS Appl Mater Interfaces; 2017 Dec; 9(49):42577-42588. PubMed ID: 29148696 [TBL] [Abstract][Full Text] [Related]
18. Biological and physical factors influencing the successful engraftment of a cultured human skin substitute. Parenteau N; Sabolinski M; Prosky S; Nolte C; Oleson M; Kriwet K; Bilbo P Biotechnol Bioeng; 1996 Oct; 52(1):3-14. PubMed ID: 18629847 [TBL] [Abstract][Full Text] [Related]
19. Normalization of epidermal calcium distribution profile in reconstructed human epidermis is related to improvement of terminal differentiation and stratum corneum barrier formation. Vicanová J; Boelsma E; Mommaas AM; Kempenaar JA; Forslind B; Pallon J; Egelrud T; Koerten HK; Ponec M J Invest Dermatol; 1998 Jul; 111(1):97-106. PubMed ID: 9665394 [TBL] [Abstract][Full Text] [Related]
20. Vitamin C enhances differentiation of a continuous keratinocyte cell line (REK) into epidermis with normal stratum corneum ultrastructure and functional permeability barrier. Pasonen-Seppänen S; Suhonen TM; Kirjavainen M; Suihko E; Urtti A; Miettinen M; Hyttinen M; Tammi M; Tammi R Histochem Cell Biol; 2001 Oct; 116(4):287-97. PubMed ID: 11702187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]